Breaking Through the Rare Disease Barrier: FDA’s Historic Approval of Denali’s Hunter Syndrome Treatment

The pharmaceutical industry celebrates a significant victory for rare disease patients as the Food and Drug Administration approved Denali Therapeutics' groundbreaking enzyme replacement therapy for Hunter syndrome, marking a pivotal…

Continue Reading Breaking Through the Rare Disease Barrier: FDA’s Historic Approval of Denali’s Hunter Syndrome Treatment
After 10 Children with Rare Diseases died, Indian MP Varnum Gandhi Warns that more Children are in Danger
source: unsplash.com

After 10 Children with Rare Diseases died, Indian MP Varnum Gandhi Warns that more Children are in Danger

  New Delhi: Recent headlines in the Hindustan Times highlighted a letter written by the leader of the Bharatiya Janata Party, Varnum Gandhi, to Health Minister Mansukh Mandaviya urging him…

Continue Reading After 10 Children with Rare Diseases died, Indian MP Varnum Gandhi Warns that more Children are in Danger
First Patient Dosed in Phase I/II Study of Experimental Gene Therapy for Cystinosis
source: pixabay.com

First Patient Dosed in Phase I/II Study of Experimental Gene Therapy for Cystinosis

According to a recent press release from the Massachusetts-based biotechnology company Avrobio, Inc., the first patient has been dosed in the Company's phase I/II clinical study of their investigational cystinosis…

Continue Reading First Patient Dosed in Phase I/II Study of Experimental Gene Therapy for Cystinosis